Notícias Corvus Pharmaceuticals Inc - CRVS | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Corvus Pharmaceuticals Inc (CRVS)
Corvus Pharmaceuticals Inc (CRVS) Notícias

Corvus Pharmaceuticals Inc (CRVS)

5,09

0,39

(8,30%)

Fechado 20 Dezembro 6:00PM

Atrasado por 15 minutos

5,031

-0,059

(-1,16%)

Após o horário de negociação: 9:54PM

Atrasado por 15 minutos

Discussões em tempo real e ideias de negociação: Negocie com confiança com nossa poderosa plataforma.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2024 Financial Results

Corvus Pharmaceuticals Granted FDA Fast Track Designation for Soquelitinib for Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2024 Financial Results on August 6, 2024

Publication of Preclinical Data in Science Signaling Demonstrated the Potential of ITK Inhibition with Soquelitinib as a Novel Approach to Treatment of Inflammatory Diseases

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Corvus Pharmaceuticals to Present at the Jefferies Global Health Conference

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 8-K - Current report

Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results

1
2
Próxima

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Corvus Pharmaceuticals

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições